Top Markets
Coin of the day
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
Rang in aandelen #7952
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
Aandeelprijs
$3.11
Marktkapitalisatie
$1.41B
Verandering (1 dag)
-1.97%
Verandering (1 jaar)
-57.22%
Land
CN
Handel Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

Categorie

Koersgeschiedenis voor Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)
Hoogste slotkoers: $3.38 op 2026-08-01

Laagste slotkoers: $1.01 op 2011-04-01
Koersgeschiedenis van Staidson (Beijing) BioPharmaceuticals Co., Ltd. van 2011 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 5.61%
2025 251.84%
2024 -26.03%
2023 -29.22%
2022 -22.33%
2021 84.25%
2020 -2.73%
2019 -4.89%
2018 -25.27%
2017 -17.93%
2016 -37.14%
2015 89.87%
2014 4.94%
2013 1.98%
2012 47.53%
2011 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$541.63 38.15%
US
$1.03K 45.67%
NL
$121.53 -12.48%
AU
$137.73 462.87%
US
$759.27 6.90%
CH